Library

X
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Neue MR-Kontrastmittel in der Leberdiagnostik Erste klinische Ergebnisse mit hepatobiliärem Eovist® (Gadolinium-EOB-DTPA) und RES-spezifischem Resovist® (SH U 555 A) (1996)
    Springer
    Der Radiologe 36 (1996), S. 124-133 
    Details
    ISSN: 1432-2102
    Keywords: Schlüsselwörter Leber ; MRT ; Kontrastmittel ; Resovist® ; Eovist® ; Key words Liver ; MRI ; Contrast agents ; Resovist ; Eovist
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary The purpose of this work is to describe our initial clinical experience (in 66 patients) with Resovist and Eovist, two new liver-specific MR contrast agents. We focus our report on safety aspects, dose finding, and optimization of technical parameters. Both contrast agents were well tolerated and improved the detectability of focal liver lesions. With Resovist, postcontrast MRI may be started as early as 10 min following injection. The dose of 8 μmol Fe/kg bodyweight was sufficient to achieve diagnostic tumor-liver contrast levels. Since Eovist can also be administered as a bolus, dynamic enhance- ment patterns may be studied for tumor characterization as well. Breath-hold T 1-weighted FLASH images were superior to other T 1-weighted techniques with and without fat saturation.
    Notes: Zusammenfassung In der vorliegenden Arbeit werden erste klinische Ergebnisse (66 Patienten) der für die Leberbildgebung entwickelten Kontrastmittel Resovist® und Eovist® vorgestellt. Es wurden Sicherheitsaspekte, Dosierungsfragen und die optimale Untersuchungstechnik am Beispiel fokaler Leberläsionen untersucht. Beide „leberspezifischen“ Kontrastmittel zeigten bei guter Verträglichkeit eine Verbesserung des Nachweises fokaler Leberläsionen. Die Untersuchung mit Resovist® kann bereits 10 min nach der Kontrastmittelinjektion erfolgen. Mit einer Dosis von 8 μmol Fe/kg Körpergewicht konnte eine ausreichender Tumor-Leber-Kontrast erzielt werden. Da Eovist® zusätzlich im Bolus injiziert werden kann, ergeben sich neben dem Nachweis fokaler Leberläsionen Möglichkeiten der Charakterisierung durch Analyse der Perfusionsmuster. Atemgehaltene T 1-gewichtete FLASH-Sequenzen waren sonstigen T 1-gewichteten Sequenzen ohne und mit Fettgesättigung überlegen.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/s001170050049
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 2
    Electronic Resource
    Electronic Resource
    Superparamegnetic iron oxides for MRI (1993)
    Springer
    European radiology 3 (1993), S. 198-212 
    Details
    ISSN: 1432-1084
    Keywords: Antibody ; Ferrite ; Iron oxide ; Macrophage ; Magnetic resonance imaging ; Magnetite ; Reticuloendothelial system
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Pharmaceutical iron oxide preparations have been used as MRI contrast agents for a variety of purposes. These agents predominantly decrease T2 relaxation times and therefore cause a decrease in signal intensity of tissues that contain the agent. After intravenous adminstration, dextran-coated iron oxides typically accumulate in phagocytic cells in liver and spleen. Clinical trials have shown that iron oxide increases lesion/liver and lesion/spleen contrast, that more lesions can be depicted than on plain MRI or CT, and that the size threshold for lesion detection decreases. Decreased uptake of iron oxides in liver has been observed in hepatitis and cirrhosis, potentially allowing the assessment of organ function. More recently a variety of novel, target-specific monocrydtalline iron oxides compounds have been used for receptor and immunospecific images. Future development of targeted MRI contrast agents is critical for organ- or tissue-specific quantitative and functional MRI.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00425895
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 3
    Electronic Resource
    Electronic Resource
    Non-invasive vascular imaging of peripheral vessels (1998)
    Springer
    European radiology 8 (1998), S. 858-872 
    Details
    ISSN: 1432-1084
    Keywords: Key words: Arteries ; Veins ; Non-invasive imaging ; Ultrasound ; Doppler studies ; Computed tomography angiography ; Magnetic resonance angiography ; Contrast agents ; Vascular studies
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract. The purpose of this review is to describe recent advances in non-invasive vascular imaging techniques and to discuss their current clinical applications for imaging of peripheral vessels. Principles for applying ultrasound, CT angiography (CTA), and magnetic resonance angiography (MRA) for non-invasive imaging of peripheral arteries and veins are presented. Clinical applications are reviewed for different vascular diseases, therapy planning, and follow-up studies. Conventional Doppler and color duplex sonography are the most cost-effective procedures to detect or rule out peripheral arterial occlusive disease (PAOD) and to provide specific recommendations for therapy. In the near future, contrast-enhanced MRA (CE MRA) with additional axial two-dimensional time-of-flight studies to search for non-anatomic runoff will replace diagnostic intra-arterial digital subtraction angiography (DSA) for planning of reconstructive surgery with acquisition slabs displaying projections similar to intra-arterial DSA. Color duplex sonography should also be the first non-invasive technique applied for the detection of peripheral aneurysms. Preoperative or preinterventional therapy planning of aneurysms may be performed by CTA or CE MRA. Compression ultrasound is the imaging procedure of choice in deep venous thrombosis (DVT). In the preoperative assessment of venous incompetence, color duplex sonography is the imaging technique which is sufficient in most cases.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/s003300050483
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 4
    Electronic Resource
    Electronic Resource
    Scintigraphic evaluation of hepatic blood flow after intrahepatic portosystemic shunt (TIPS) (1997)
    Springer
    European journal of nuclear medicine 24 (1997), S. 635-641 
    Details
    ISSN: 1619-7089
    Keywords: Key words: Liver cirrhosis ; Portal hypertension ; Transjugular intrahepatic portosystemic shunt ; Liver perfusion scintigraphy ; Liver blood flow ; TIPS
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract. In patients with liver cirrhosis a transjugularly placed intrahepatic portocaval shunt (TIPS) is a non-surgical portosystemic device which aims to reduce portal venous pressure. In comparison with Doppler sonography, we evaluated in 28 patients the diagnostic impact of liver perfusion scintigraphy (with technetium-99m diethylene triamine penta-acetic acid) in the assessment of changes in the hepatic blood flow after TIPS shunting. The arterial and portal contributions to hepatic flow were calculated from the areas under the biphasic time-activity curve. In the course of TIPS shunting, patency is threatened by reocclusion. Angiography is the gold standard for TIPS shunt reassessment. However, there is a need for a less invasive diagnostic procedure, such as scintigraphy or Doppler sonography, for the early detection of shunt insufficiency. Scintigraphy demonstrated that prior to TIPS shunting the portal venous contribution to hepatic perfusion was reduced to 29.2%, this reduction being due to portal hypertension. After TIPS placement a significant increase in portal venous perfusion was observed (38.2%; P〈0.02). TIPS shunt occlusion was identified in patients by a significant reduction in the scintigraphically measured portal venous contribution to hepatic blood flow. Hepatic perfusion scintigraphy appears to be a valuable method to determine the immediate effect of TIPS on hepatic blood flow. Post-TIPS follow-up studies of hepatic haemodynamics by liver perfusion scintigraphy appear able to contribute to the detection of TIPS shunt occlusion before the clinical consequences of this complication have become apparent.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00841401
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 5
    Electronic Resource
    Electronic Resource
    Scintigraphic evaluation of hepatic blood flow after intrahepatic portosystemic shunt (TIPS) (1997)
    Springer
    European journal of nuclear medicine 24 (1997), S. 635-641 
    Details
    ISSN: 1619-7089
    Keywords: Liver cirrhosis ; Portal hypertension ; Transjugular intrahepatic portosystemic shunt ; Liver perfusion scintigraphy ; Liver blood flow ; TIPS
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract In patients with liver cirrhosis a transjugularly placed intrahepatic portocaval shunt (TIPS) is a non-surgical portosystemic device which aims to reduce portal venons pressure. In comparison with Doppler sonography, we evaluated in 28 patients the diagnostic impact of liver perfusion scintigraphy (with technetium-99m diethylene triamine penta-acetic acid) in the assessment of changes in the hepatic blood flow after TIPS shunting. The arterial and portal contributions to hepatic flow were calculated from the areas under the biphasic timeactivity curve. In the course of TIPS shunting, patency is threatened by reocclusion. Angiography is the gold standard for TIPS shunt reassessment. However, there is a need for a less invasive diagnostic procedure, such as scintigraphy or Doppler sonography, for the early detection of shunt insufficiency. Scintigraphy demonstrated that prior to TIPS shunting the portal venons contribution to hepatic perfusion was reduced to 29.2%, this reduction being due to portal hypertension. After TIPS placement a significant increase in portal venous perfusion was observed (38.2%;P〈0.02). TIPS shunt occlusion was identified in patients by a significant reduction in the scintigraphically measured portal venons contribution to hepatic blood flow. Hepatic perfusion scintigraphy appears to be a valuable method to determine the immediate effect of TIPS on hepatic blood flow. Post-TIPS follow-up studies of hepatic haemodynamics by liver perfusion scintigraphy appear able to contribute to the detection of TIPS shunt occlusion before the clinical consequences of this complication have become apparent.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1007/BF00841401
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...